Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

NCT00730288 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue
Dengue Fever
Dengue Hemorrhagic Fever
Dengue Virus

Interventions

BIOLOGICAL: Chimeric dengue serotype (1, 2, 3, 4)
BIOLOGICAL: Chimeric dengue serotype (1, 2, 3, 4)
BIOLOGICAL: Chimeric dengue serotype (1, 2, 3, 4)

Sponsor

Sanofi